Introduction {#s1}
============

Bacterial quorum sensing (QS) often controls factors that benefit cells in groups; it controls cooperative activities. A well-studied type of QS common to a number of Proteobacteria species is mediated by acyl-homoserine lactone (AHL) signals. AHLs are made by members of the LuxI family of signal synthases. The AHLs can diffuse in and out of cells. At sufficient cell densities, the AHLs accumulate to concentrations needed for expression of specific genes by binding signal receptors of the LuxR family of transcriptional regulators (for reviews of QS see ([@bib10])). In some bacterial species, QS controls just a few genes and in others it controls hundreds of genes. Genes for production of secreted or excreted products are overrepresented in AHL quorum sensing regulons. These extracellular products have at least in some cases been shown to serve as public goods. Any member of a group can benefit from the public good regardless of whether that individual has contributed its share of the good ([@bib30]). There is a metabolic cost associated with QS and QS-activation of gene expression. QS control of public goods has been studied in some detail in *Pseudomonas aeruginosa*. Because QS activates production of extracellular proteases, QS signal receptor mutants have a fitness advantage over the wild type when growth is on milk protein as the sole carbon and energy source ([@bib8]; [@bib20]). The receptor mutant fitness advantage presents a conundrum; how is QS-mediated cooperation preserved?

QS itself can be considered a cooperative trait, the QS signal is a public good, and QS is susceptible to exploitation by QS mutant social cheats. In *P. aeruginosa,* three mechanisms of QS cheater restraint have been demonstrated. The first is a direct benefit-based strategy called metabolic constraint ([@bib21]; [@bib7]); Quorum sensing activates genes coding for public goods (such as extracellular proteases), as well as a limited set of privately utilized goods (such as a hydrolase that allows producing cells to utilize adenosine). When cells are supplied with both casein and adenosine, QS signal receptor (LasR) mutant cheats are penalized and constrained ([@bib7]). A second mechanism has been called metabolic prudence ([@bib31]) where the QS-controlled public good is only made when it's production is not costly. Metabolic prudence minimizes the cost of cooperation. Recently, a mechanism whereby *P. aeruginosa* cooperators punish or police cheats has been described. QS competent cooperators produce cyanide and are more resistant to cyanide than QS mutant cheats, and thus the cooperators can constrain cheats by slowing their growth with cyanide ([@bib29]). The *P. aeruginosa* policing is a rare example of this sort of activity in bacteria, and because cyanide production and resistance has some semblance to a toxin-immunity-like mechanism we hypothesis that QS activation of toxin-immunity systems might have some generality as a policing mechanism where QS bacteria can control QS mutants.

We recently used RNAseq to identify genes in the *Burkholderia thailandensis* QS regulon ([@bib15]). *B. thailandensis* has three AHL QS systems, BtaR1-I1, BtaR2-I2 and BtaR3-I3 ([@bib27]; [@bib3]; [@bib9]). Together, the QS systems control hundreds of genes. The BtaR1-I1 regulon appears to be the largest as BtaR1 regulates \>150 genes ([@bib15]). We queried the transcriptomics data and discovered that expression of several genes shown to encode Type VI secretion system (T6SS) substrates, including characterized toxins and their cognate immunity or antitoxin genes, are activated by QS. Expression of a toxin and its antitoxin results in a toxin-resistant producer cell, which can deliver toxins via the secretion apparatus via cell-cell contact to a sensitive cell thereby inhibiting growth of the sensitive cell ([@bib19]). We show that T6S provides wild-type *B. thailandensis* with an ability to constrain BtaR1 mutants in a contact-dependent manner. This supports the hypothesis that QS activation of toxin-immunity systems can serve as a policing mechanism to control QS mutants growing among QS competent wild-type cells. Our findings also reveal yet another role for T6S in bacteria. T6S has been shown to provide a competitive interspecies or interstrain advantage, and some T6Ss have been shown to play a role in bacterial virulence ([@bib22]; [@bib23]). Here we describe intraspecific control of QS mutants. This provides a rationale for why T6S toxin and immunity genes might be under QS control.

Results {#s2}
=======

The BtaR1 mutant has a growth advantage over the wild type in LB broth cocultures {#s2-1}
---------------------------------------------------------------------------------

To assess the fitness of the *B. thailandensis* QS mutants in competition with their parent, we cocultured the wild type with signal blind QS mutants. We used signal-blind mutants BtaR1^-^, BtaR2^-^ or BtaR3^-^ (which each have mutations in the LuxR homolog genes *btaR1, btaR2,* or *btaR3*) because they cannot respond to signals made by QS-proficient bacteria in coculture. The starting inoculum was 99% wild type and 1% signal-blind mutant. Cocultures were transferred to fresh medium at 24 hr intervals as described in the Materials and methods (there were about 12 doublings per day), and at each interval the relative abundance of parent and mutant was determined. After 3 days in broth, the BtaR1^-^ mutant showed an increase from 1% of the total population to 50% ([Figure 1A](#fig1){ref-type="fig"}). The BtaR2^-^ and BtaR3^-^ mutants did not have a growth advantage over the parent and remained at about 1% of the population throughout the experiment ([Figure 1A](#fig1){ref-type="fig"}).10.7554/eLife.14712.003Figure 1.Growth of the wild type and QS mutants in LB broth and on an agar surface.(**A**) In LB broth, the wild type (strain E264) was mixed with the BtaR1- mutant CM157, the BtaR2- mutant CM159 or the BtaR3- mutant CM161 at a starting mutant relative abundance of 1%. All mutants were KmR. As a control we mixed the wild type with CM218, a KmR strain derived from the wild type. Results are percent of total colonies that are KmR (% mutants). The control shows there is little cost associated with the KmR marker. (**B**) LB broth pure culture growth curves of CM224, a TpR wild-type strain and the KmR BtaR1- mutant. Data for [Figure 1B](#fig1){ref-type="fig"} for the statistical analysis described in the text are in the [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). (**C**) 24-hour LB broth coculture. The TpR marked wild type) mixed with the KmR marked wild type), or the BtaR1 mutant. KmR bacteria were started at 1% of the population and each coculture was grown in a flask for 24 hr. Bacteria were enumerated by colony counts for total coculture yield (CFU/mL) and percent KmR mutants in the population (open symbols are CFU/mL, closed symbols are percent of mutants). Bars show the mean and range of at least three biological replicates. (**D**) Agar surface competitions. Wild type with the BtaR1- mutant, the BtaR2- mutant or the BtaR3- mutant at a starting mutant abundance of 1%. As a control we mixed the wild type with the KmR strain derived from the wild type. Data are means of at least three biological replicates. Some ranges are not visible, as they were small and within the size of the symbols.**DOI:** [http://dx.doi.org/10.7554/eLife.14712.003](10.7554/eLife.14712.003)10.7554/eLife.14712.004Figure 1---source data 1.Experimental data for the statistical analysis for [Figure 1B](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.14712.004](10.7554/eLife.14712.004)

Growth rates and yields of the BtaR1^-^ mutant and the parent in pure culture were similar with a small but reproducible difference during late logarithmic phase where the parent showed slightly slower growth than the mutant ([Figure 1B](#fig1){ref-type="fig"}). At 7 hr post-inoculation in pure liquid culture, there was a reproducible and statistically significant increase in cell number for the BtaR1^-^ mutant; the average cell yield of the wild-type parent was 1.8 x 10^9^ CFU/mL and the BtaR1- mutant was 2.6 x 10^9^ CFU/mL (*p* value=0.0041) ([Figure 1B](#fig1){ref-type="fig"}, data for this figure can be found in the [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). The slight difference in post-exponential growth rate coincides with the point during growth when we expect QS gene expression to be most evident, and when the BtaR1^-^ mutant begins to take over the population ([Figure 1C](#fig1){ref-type="fig"}). We attribute the slight influence on growth of the parent to the cost of BtaR1-mediated QS and QS-dependent gene expression. Previous experiments showed that BtaR1 controls aproximately 164 genes in post-exponential phase, whereas BtaR2 and BtaR3 controlled 20 and 12, respectively ([@bib15]). We suspect that the larger BtaR1 regulon may impart a larger burden on growth than either the smaller BtaR2 or BtaR3 regulons.

The BtaR1 mutant does not have a growth advantage over the wild type in solid surface-grown cocultures {#s2-2}
------------------------------------------------------------------------------------------------------

In contrast to broth cocultures where the BtaR1^-^ mutant had a strong fitness advantage, the BtaR1^-^ mutant had no advantage on agar plate grown cocultures at 30°C ([Figure 1D](#fig1){ref-type="fig"}) or 37°C (data not shown). The starting and final percent of the BtaR1^-^ mutant after four daily plate transfers (about 36 doublings in total) was 1% of the total *B. thailandensis* population. The BtaR2^-^ and BtaR3^-^ mutants had no fitness disadvantage on agar plates, as was true for broth cocultures ([Figure 1D](#fig1){ref-type="fig"}).

QS regulation of known and predicted T6S effector and immunity genes {#s2-3}
--------------------------------------------------------------------

Among the many growth conditions that vary between liquid- and agar-grown cocultures is a difference in cell-to-cell contact. Cell contact is minimal during growth in broth but does occur when cells are grown on a solid agar surface. This led us to ask if QS controls contact-dependent growth inhibition systems. We previously reported that QS-1 activated the contact-dependent inhibition (CDI) system encoded by the *cdiAIB* genes ([@bib15]). However, CDI does not limit the outgrowth of the BtaR1^-^ mutant during agar-grown cocultures. We next asked whether QS regulates other contact-dependent growth inhibitory factors. *B. thailandensis* contains five different T6SSs, at least one of which is used for interspecies competition (T6SS-1) ([@bib22]). The T6SS-1 comprises a pathway that delivers effector proteins to neighboring cells upon direct cell contact. Some T6SS-1 effectors have been characterized and are toxic ([@bib19]). *B. thailandensis* is immune to the toxins because it produces cognate immunity proteins ([@bib19]). We asked if the T6SS-1 was under QS-control by querying *B. thailandensis* QS transcriptomics data ([@bib15]) for genes for the T6SS-1 apparatus or for previously identified substrates ([@bib17]). Although genes for the T6SS-1 apparatus are not QS-controlled, we observed that QS activates nine genes for T6SS-1 substrates, as well as an additional eight that are either adjacent to a substrate gene, fall within the same gene cluster, or include a putative T6SS-1 immunity gene ([Figure 2A](#fig2){ref-type="fig"}).10.7554/eLife.14712.005Figure 2.Map of QS-controlled genes for T6SS-1 substrates and solid-surface competition experiments with T6SS-1 mutants.(**A**) Genes coding for known or putative T6SS-1 substrates ([@bib17]) are shaded grey and genes controlled by QS ([@bib15]) are outlined in red. BTH_I2698 is the *tle1* toxin gene and BTH_I2699 is the *tli1* immunity gene ([@bib18]). The neighboring genes, BTH_I2701 and BTH_I2702 are paralogs of *tle1* and *tli1*. (**B**). Agar surface competition experiments. These experiments were started with a relative abundance of 10% target, CM316 Tp^R^ T6SS-1 immunity mutant (△*tle1*△BTH_I2699-703) or CM218 Tp^R^ wild type (WT). The inhibitor strains all carried a Km^R^ marker; The wild type inhibitor was CM224, The BtaR1^-^ mutant (△R1) was CM157, the BtaR2^-^ mutant (△R2) was CM159, and the BtaR3^-^ mutant (△R3) was CM161. Target cell abundance after one 24 hr round of colony growth was determined by plate counting. Data are from three biological replicates. The asterisk (\*) indicates statistical significance between the CFU/mL measured in the WT or BtaR1 culture, as determined by an unpaired t test. Data can be found in the [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.14712.005](10.7554/eLife.14712.005)10.7554/eLife.14712.006Figure 2---source data 1.Experimental data for statistical analysis of the results in [Figure 2](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.14712.006](10.7554/eLife.14712.006)

QS mutants show a T6SS-1-mediated killing defect {#s2-4}
------------------------------------------------

Ten of 15 genes in a cluster spanning BTH_I2691-BTH_I2705 were QS activated ([Figure 2A](#fig2){ref-type="fig"}). Two of these 10 QS-activated genes, BTH_I2698 (*tle1*) and BTH_I2699 (*tli1*), are a known T6S toxin and immunity pair that code for a lipase and immunity protein ([@bib18]). When a *B. thailandensis* recipient cell does not produce the Tli1 immunity protein, Tle1 acts as a T6SS-1-delivered antibacterial factor ([@bib18]). In addition to *tle1* and *tli1*, QS activates neighboring *tle1* and *tli1* paralogs (BTH_I2701 and BTH_I2702) ([Figure 2A](#fig2){ref-type="fig"}). To test the hypothesis that QS activates T6SS-1-mediated killing in *B. thailandensis,* we competed the wild type or the signal blind QS mutants against a *B. thailandensis* mutant lacking *tle1, tli1*, and adjacent immunity paralogs (*△tle1*BTH_I2699-2703). Consistent with a previous publication ([@bib18]), the wild type outcompeted the T6SS-1 effector and immunity mutant ([Figure 2B](#fig2){ref-type="fig"}). We also found that the BtaR1^-^ mutant was impaired in inhibition of the effector and immunity mutant ([Figure 2B](#fig2){ref-type="fig"}). The BtaR2^-^ and BtaR3^-^ mutants each showed wild-type levels of inhibition ([Figure 2B](#fig2){ref-type="fig"}). We propose that the T6SS-1-mediated killing defect in the BtaR1^-^ mutant results from its inability to fully activate expression of one or more T6S toxin genes.

The ability of wild-type *B. thailandensis* to compete with a BtaR1^-^mutant during agar growth depends on T6S {#s2-5}
--------------------------------------------------------------------------------------------------------------

We hypothesized that the QS-activated T6SS-1 effector and immunity proteins in wild-type bacteria restrict the proliferation of BtaR1^-^ mutants upon cell contact in cocultures. This hypothesis was tested in LB agar competition experiments with a △*clpV* T6SS-1 secretion apparatus mutant (T6SS-1^-^) and a BtaR1^-^T6SS-1^-^ mutant. In this experiment, the BtaR1^-^T6SS-1^-^ mutant rose in frequency from about 1% to nearly 25% of the population ([Figure 3A](#fig3){ref-type="fig"}). When the T6SS-1^-^ mutants were complemented with *clpV* to restore the function of the T6SS-1 apparatus, a *btaR1* mutation no longer conferred a coculture growth advantage ([Figure 3A](#fig3){ref-type="fig"}). As predicted, in broth coculture, the BtaR1^-^ T6SS-1^-^ mutant showed a strong fitness advantage during growth with the T6SS-1^-^ mutant ([Figure 3B](#fig3){ref-type="fig"}). This fitness advantage was nearly identical to the fitness advantage of the BtaR1^-^ mutant during coculture in broth with the wild-type parent ([Figure 1A](#fig1){ref-type="fig"}) and to a T6SS-1 complemented competition ([Figure 3B](#fig3){ref-type="fig"}).10.7554/eLife.14712.007Figure 3.The contributions of T6SS-1 in policing BtaR1^-^ mutants.Competitions were on (**A**) LB agar plates for solid surface cocultures or in (**B**) LB broth for liquid cocultures. The T6SS-1**^-^**mutant (△*clpV*) was mixed with the Tp^R^ BtaR1^-^ T6SS-1^-^ mutant ES9 (open red squares) or the Km^R^ T6SS-1^-^ mutant ES18 (open blue downward triangle). The *clpV* complemented T6SS-1- mutant *△clpV*-comp was mixed with the *clpV* complemented BtaR1- T6SS-1- mutant ES16 (open orange circles). For liquid cultures, the wild type (strain E264) was mixed with CM316 Tp^r^ T6SS-1 toxin/ immunity mutant (△*tle1*△BTH_I2699-703) (black crosshatch). This served as a control to demonstrate T6SS-1-mediated killing does not occur in liquid broth cocultures. Results are the mean of at least three biological replicates. Ranges were within the size of the symbols.**DOI:** [http://dx.doi.org/10.7554/eLife.14712.007](10.7554/eLife.14712.007)

We reason that the parent, with an intact QS system, would express quorum-activated T6SS-1 toxin and immunity proteins, whereas the BtaR1^-^ mutant should not fully induce its T6SS-1 effectors and immunity factors. As such, the BtaR1^-^ mutant would be sensitive to cell contact-dependent growth inhibition or killing by the wild type. This can be considered a policing mechanism whereby QS-proficient cooperators hinder the success of individuals incapable of cooperation.

Discussion {#s3}
==========

We present evidence that QS control of T6SS-1-mediated toxicity and immunity genes allows QS competent members of *B. thailandensis* colonies to police against BtaR1^-^ QS mutants. During planktonic growth in broth where T6SS-1 does not function due to limited cell contact, BtaR1^-^ mutants have a substantial fitness advantage over wild-type cells, presumably because of the cost associated with BtaR1-dependent activities. Policing of social deviants in *Myxococcus xanthus* and *Pseudomonas aeruginosa* has been reported previously ([@bib16]; [@bib20]). Here we describe a novel mechanism, for limiting quorum sensing mutant growth in bacterial groups.

Several functions have been ascribed to T6S. *B. thailandensis* T6S-mediated killing is active against Proteobacteria species other than *B. thailandensis* and is thought to be important for interspecies competition ([@bib22]). T6Ss occur in many species of Proteobacteria where they can provide an advantage over competing species (see [@bib19] for review). We note that in other organisms including, *Pectobacterium atrosepticum* ([@bib1]), *P. aeruginosa* ([@bib14]), *Aeromonas hydrophila* ([@bib12] *Yersinia pseudotuberculosis* ([@bib32]), *Chromobacterium violaceum* ([@bib25]), *Vibrio cholerae* ([@bib33]), *Vibrio alginolyticus*, ([@bib24]), and *Vibrio parahaemolyticus* ([@bib28]), QS regulates genes for the T6S apparatus (not the effector and immunity factors as we describe for *B. thailandensis*). We suspect QS regulation of the T6S apparatus might play a role in policing QS mutants during polymicrobial competitions or in other scenarios where T6S might benefit the producing cell. Furthermore, we note that other types of toxin-antitoxin systems have been reported to be under control of other non-AHL-mediated quorum sensing systems, for example the *E. coli mazEF* encoded toxin-antitoxin genes are controlled by a linear pentapeptide quorum sensing signal ([@bib13]).

Under the conditions of our experiments the BtaR1-BtaI1 QS system carries with it a metabolic cost, which is evident in broth culture competition experiments and to a lesser extent in pure broth culture grow curves. The BtaR2-BtaI2 and BtaR3-BtaI3 QS systems do not appear to carry this large cost. We describe a mechanism by which wild-type populations can mitigate the cost of BtaR1-BtaI1 gene regulation by hindering the growth of QS mutants via regulation of cell-contact-dependent toxin and immunity proteins. This is a form of microbial policing; QS-proficient bacteria are outcompeted in populations of signal blind non-cooperators in the absence of the T6S cell-contact growth inhibition system. It is interesting that BtaR1 also promotes aggregation of cells under some conditions ([@bib3]). One can imagine that this system brings cells into close proximity where they can resist infiltration by other strains and species while at the same time protect themselves against social deviant BtaR1 mutant bacteria ([Figure 4](#fig4){ref-type="fig"}).10.7554/eLife.14712.008Figure 4.A policing model where QS control of T6S contact-dependent killing (effector and immunity proteins) enforces cooperation.(**A**) The bacterium on the left depicts a situation where QS co-regulates a public good with the T6SS-1 effector and immunity factors. Under these conditions, QS-proficient bacteria (cooperators, shown as white cells) limit the proliferation of a QS mutant (potential cheater, black cell) in a population. (**B**) In this situation, QS no longer co-regulates public good production with the T6SS-1 killing mechanism. Without co-regulation of the killing mechanism, QS mutants (potential cheaters, black cells) outcompete the wild type cooperators (white cells).**DOI:** [http://dx.doi.org/10.7554/eLife.14712.008](10.7554/eLife.14712.008)

Materials and methods {#s4}
=====================

Bacterial strains, plasmids, and growth conditions {#s4-1}
--------------------------------------------------

Bacterial strains and plasmids are listed in [Table 1](#tbl1){ref-type="table"}. Bacteria were grown in Luria-Bertani (LB) broth (10 g tryptone, 5 g yeast extract, and 5 g NaCl per liter) supplemented with 50 mM morpholinepropanesulfonic acid (MOPS) buffer (pH 7.0) or on LB MOPS agar plates (LB MOPS plus 2% agar). Antibiotics were added at the following concentrations as appropriate: for *Escherichia coli*, 100 μg/mL trimethoprim (Tp), 25 μg/mL zeocin (Zeo), and 100 μg/mL ampicillin (Ap) and for *B. thailandensis*, 100 μg/mL Tp, 2 mg/mL Zeo, and 1 mg/mL Km. Except where indicated, bacteria were grown in broth at 37°C with shaking or on agar plates at 30°C.10.7554/eLife.14712.009Table 1.Bacterial strains and plasmids used in this study**DOI:** [http://dx.doi.org/10.7554/eLife.14712.009](10.7554/eLife.14712.009)Bacterial strain or plasmidGenotype or description^a^SourceBacterial strainsDH10B*E. coli* cloning vehicleInvitrogenE264Wild-type *B. thailandensis*([@bib2])JBT107E264 *△btaR1*([@bib3])JBT108E264 *△btaR2*([@bib3])JBT109E264 *△btaR3*([@bib3])CM157JBT107 *glmS1 attn7::Km*; Km^R^This studyCM159JBT108 *glmS1 attn7::Km*; Km^R^This studyCM161JBT109 *glmS1 attn7::Km*; Km^R^This studyCM218E264 *glmS1 attn7::Km*; Km^R^This studyCM224E264 *glmS1 attn7::Tp*; Tp^R^This studyBT03399E264 *btaR1139*::ISlacZ/PrhaBo-Tp/FRT; Tp^R^([@bib11])△*clpV*E264 △BTH_I2958([@bib22])△*clpV*-comp△*clpV* att Tn7-miniTn7T-Tp-S12-BTH_I2958([@bib22])ES9*△clpV btaR1139*::ISlacZ/PrhaBo-Tp/FRT; Tp^R^This studyES18△*clpV glmS1 attn7::Tp*; Tp^R^This studyES14*△clpV btaR1139*::ISlacZ/PrhaBo scar; Tp^S^This studyES15ES14 *glmS1 attn7::P~S12~-clpV, Tp*; Tp^R^This studyES16ES15 *glmS2 attn7::Km*; Tp^R^, Km^R^This Study△*tle1*△BTH_I2699-703E264 *△BTH_I2698-BTH_I2703*([@bib18])CM316*△tle1 △12699-2700 glmS1 attn7::Tp*; Tp^R^This studyPlasmidspTNS2R6K replicon TnsABC+D vector([@bib4])pUC18T-mini-Tn7T-*Tp*Cloning vector([@bib5])pUC18T-mini-Tn7T-*Km*-FRTCloning vector([@bib6])pFLPe2Flp recombinase-expressing vector; Zeo^R^([@bib6])pUC18T-miniTn7T-Tp-S12-BTH_I2958*clpV* complementation contruct (*P~S12~-clpV*)([@bib22])

Mutant construction {#s4-2}
-------------------

To generate Tp-resistant mutants we transformed strains E264, △*clpV*, and △*tle^BT^* △12699--2700, with pTNS2 and pUC18T-mini-Tn7T-*Tp* as described elsewhere ([@bib15]) to make CM224 (E264 *glmS1 attn7::Tp*), ES18 (△*clpV glmS1 attn7::Km*), and CM316 (△tle^BT^△12699-2700*glmS1 attn7::Tp*), respectively. To generate Km-resistant mutants we transformed *B. thailandensis* strains JBT107, JBT109, JBT110, E264, and CM183 with pTNS2 and pUC18T-mini-Tn7T-*km* to generate CM157 (*△btaR1 glmS1 attn7::Km*), CM159 (*△btaR2 glmS1 attn7::Km*), and CM161 (*△btaR3 glmS1 attn7::Km*). Genomic DNA (gDNA) from strain BT03399 was used to introduce a *btaR1* mutation into △*clpV* to make ES9 (*△clpV btaR1139*::ISlacZ/PrhaBo-Tp/FRT; Tp^R^) by natural transformation as previously described ([@bib26]). The trimethoprim resistance cassette was removed from strain ES9 to make strain ES14 (*△clpV btaR1139*::ISlacZ/PrhaBo scar) by using pFLPe2 as previously described ([@bib6]). The *clpV* complementation construct pUC18T-miniTn7T-Tp-S12-BTH_I2958 ([@bib22]) was introduced into ES14 by electrotransformation with pTNS2 as described elsewhere (8) to generate ES15 (ES14 *glmS1 attn7::P~S12~-clpV, Tp*). ES16 (ES15 *glmS2 attn7::Km*; Tp^R^, Km^R^) was then made by transforming ES15 with pTNS2 and pUC18T-mini-Tn7T-*km.* We used PCR to confirm that the antibiotic resistance markers and complementation construct were inserted at the *attn7* site near *glmS1* or *glmS2* in all of the constructs..

LB broth growth experiments {#s4-3}
---------------------------

For single strain growth curves bacteria were grown in 15 mL of broth in 125-mL flasks with an overnight culture as inoculum to a starting optical density at 600 nm of 0.05. We sampled cultures every hour and determined cell numbers by plate counting. For competition experiments we used inocula from overnight cultures at a ratio of 99:1 as indicated. As above, the starting optical densities were 0.05 in a volume of 15 mL in a 125-mL flask. Abundances of each strain were determined by plate counting on selective media.

Long-term *B. thailandensis* competition experiments {#s4-4}
----------------------------------------------------

Logarithmic phase cultures of each competing strain were diluted in fresh LB medium to an optical density of 0.2. The diluted cultures were then mixed at a 99:1 or 9:1 ratio where indicated and 20 μl of the mixture was spotted on an agar plate or inoculated into 4 mL of broth in a 16 mm test tube. The solid surface-grown cocultures were incubated at 30°C and the liquid-grown cocultures were incubated with shaking at 37°C to minimize aggregation. At 24 hr intervals cells were harvested, counted and used to inoculate a new broth or plate. Colonies on plates were scraped from the agar surface, suspended in phosphate buffer (pH 7.0), and subjected to water bath sonication for 10 min to disrupt aggregates. The cells in phosphate buffer were diluted to an optical density of 0.2. Twenty μl of the density-adjusted cell suspension was spotted onto an agar plate for another round of competition. Bacteria grown in broth were similarly diluted and 20 μL of the density adjusted cell suspension was inoculated into a test tube with 4 mL broth. At each transfer cells of each of the competing strains were enumerated by selective plate counting.
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Thank you for submitting your article \"Quorum sensing control of Type VI secretion factors restricts the proliferation of quorum-sensing mutants\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a Reviewing Editor. Michael Marletta has served as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The main new finding of this study, which builds upon previous work from the Greenberg laboratory, is that a Type 6 secretion system (T6SS) acts as a surveillance system to eliminate social cheaters that have mutations in quorum sensing (QS), a public good. This is achieved by placing toxic T6SS-delivered effector/immunity systems under QS control.

Essential revisions:

Overall, all three reviewers thought your study was straightforward and interesting but suggest the following:

1\) Although the authors show that a B.t. region coding for a number of T6SS toxin/immunity genes plays a role in this \"policing\" or surveillance of mutants defective for QS, it is not clear if one or more T6SS toxin/immunity genes is directly involved. This ambiguity could be addressed by ectopic expression of immunity gene(s) linked to these toxins (Tle1/Tli1 and paralogs) together with competition experiments ([Figures 1 & 2B](#fig1){ref-type="fig"}). If it turns out that this experiment is not straightforward, the authors should comment on what they have tried.

2\) The figures are not optimal and need the following revisions:

[Figures 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}: Keys to each of the different strains or types of information should be provided in the Figure (especially if not all lines are defined in the figure legend as is the case for 1C).

[Figure 1C](#fig1){ref-type="fig"}: What does the CFU/mL data contribute to the interpretation of this experiment? I think it would be clearer with just the mutant% .

[Figure 2A](#fig2){ref-type="fig"}: This figure is so compressed that little useful information is presented. A number of T6SS effectors and co-listing of those believed to be regulated by QS BtaR1 are shown but only the BTH_12699-12703 region was examined in the study. It would be more useful to have a more complete genomic representation labeling each of the potential effectors and immunity proteins, possibly in a supplementary figure. Again the shading and colors should be defined in the figure (with more information about the parameters for considering a gene product a T6SS-1 substrate or QU-regulated provide in the legend).

[Figure 2B](#fig2){ref-type="fig"}: An appropriate control would have been to use a Type VI mutant as the inhibitor versus the *tle1* mutant to demonstrate it no longer inhibits growth.

[Figure 4A and B](#fig4){ref-type="fig"}: It is not very clear what is going on in the left panels.

Information about reproducibility need to be provided for some data panels.
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Author response

*Essential revisions: Overall, all three reviewers thought your study was straightforward and interesting but suggest the following: 1) Although the authors show that a B.t. region coding for a number of T6SS toxin/immunity genes plays a role in this \"policing\" or surveillance of mutants defective for QS, it is not clear if one or more T6SS toxin/immunity genes is directly involved. This ambiguity could be addressed by ectopic expression of immunity gene(s) linked to these toxins (Tle1/Tli1 and paralogs) together with competition experiments ([Figure 1 & 2B](#fig1){ref-type="fig"}). If it turns out that this experiment is not straightforward, the authors should comment on what they have tried.* We agree with the reviewer. The data demonstrate "T6S plays a role in Bt "policing" of QS-defective mutants, but it remains unknown which QS-controlled T6 effector and immunity factors are responsible for this policing activity." Based on our current understanding of T6S and delivery of toxins to other bacteria we assume there are several secreted effectors involved in policing. This is the complication that led us away from the suggested experiments.

Our previously reported RNAseq data showed that QS controls a total of nine different proteins secreted by the T6S system, as well as an additional eight that may be associated with the activity of these secreted factors or their immunity. Of these 17 QS-controlled factors, only the activities of *tle1*and *tli1* have been characterized. For the others that are uncharacterized, we do not know which are truly toxins and which have cognate immunity factors.

The reviewers suggested an experiment to ectopically and constitutively express the *tle1* and *tli1* effector and immunity pair in the QS mutant and perform competition experiments with the wildtype. We decided against this approach because there are so many other (uncharacterized) toxin/immunity factors in the TSS-1 system. We would need to ectopically and constitutively express all QS-controlled T6S immunity factors and in doing so we would compromise the experiment by putting a heavy burden on the expressing strain. At the very least this sort of experiment would be technically challenging and require an enormous effort.

*2) The figures are not optimal and need the following revisions:*

[Figures 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}: Keys to each of the different strains or types of information should be provided in the Figure (especially if not all lines are defined in the figure legend as is the case for 1C).

[Figures 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"} have been modified to include keys. Please advise if further clarification is needed.

*[Figure 1C](#fig1){ref-type="fig"}: What does the CFU/mL data contribute to the interpretation of this experiment? I think it would be clearer with just the mutant% .*

[Figure 1C](#fig1){ref-type="fig"} shows that the BtaR1 mutant begins to increase in a coculture with WT as the coculture population enters into post-exponential phase and stationary phase. We believe the CFU/mL data are important as they show the phase of bacterial growth. This is relevant as QS-controlled processes are regulated in a cell density-dependent manner and most are induced as cells enter post-exponential phase. We agree that it is perhaps a point for the expert, but one an expert would find problematic if missing.

*[Figure 2A](#fig2){ref-type="fig"}: This figure is so compressed that little useful information is presented. A number of T6SS effectors and co-listing of those believed to be regulated by QS BtaR1 are shown but only the BTH_12699-12703 region was examined in the study. It would be more useful to have a more complete genomic representation labeling each of the potential effectors and immunity proteins, possibly in a supplementary figure. Again the shading and colors should be defined in the figure (with more information about the parameters for considering a gene product a T6SS-1 substrate or QU-regulated provide in the legend).*

In an effort to make [Figure 2A](#fig2){ref-type="fig"} more clear, we have modified the gene images and added locus tags at each QS-controlled gene. A key has also been added to supplement the information in the figure legend. We chose not to include a list of genes as this information can be found in a previous publication, where all the details of strains used and RNAseq methods and analysis are described.

Also, we highlight that many genes are QS-controlled and potentially associated with T6SS-1. However, [Figure 2B](#fig2){ref-type="fig"} examines only a subset of these, the *tle1/ tli1* toxin and immunity pair and neighboring paralogs. We hope the modified figure makes this issue more clear as well.

*[Figure 2B](#fig2){ref-type="fig"}: An appropriate control would have been to use a Type VI mutant as the inhibitor versus the tle1 mutant to demonstrate it no longer inhibits growth.*

We did not include this because we already show this experiment in a prior publication (<http://doi.org/10.1016/j.chom.2012.04.007>).

*[Figure 4A and B](#fig4){ref-type="fig"}: It is not very clear what is going on in the left panels.*

We have reworked both the left panel and the figure legend.

*Information about reproducibility need to be provided for some data panels.*

The legends for each figure state that data are from a minimum of three biological replicates. Please advise if any information is missing. Note that in some instances, the error bars are quite small and are not visible.
